Review



inpouch t vaginalis culture system  (BioMed Diagnostics Inc)


Bioz Manufacturer Symbol BioMed Diagnostics Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    BioMed Diagnostics Inc inpouch t vaginalis culture system
    2A: 96-well plate used for 5-nitroimidazole drug susceptibility testing. 2B: Graphical representation of a portion of the 96 well plate for the 5-nitroimidazole drug susceptibility testing. Rows A and H are DMSO control lanes, while lanes B-G contain the 5-nitroimdazoles tested for specific T. <t>vaginalis</t> isolates tested in triplicates. 50 μl of media is initially added to each well. Next, 50 μl of drug/media is added to column 1 rows B-G, while 50 μl of DMSO/media are added to A and H and then serially diluted from left to right (column 1 [400 μg/ml] to column 12 [0.2 μg/ml]). 150 μl of the T. vaginalis sample is added to each well from the lowest concentration to the highest (column 12 [0.2 μg/ml] to column 1 [400 μg/ml]). The plates are then incubated for 48 to 52 hours before being read on an inverted microscope. MLC is determined when no motile TV is observed for all three wells with the same concentration.
    Inpouch T Vaginalis Culture System, supplied by BioMed Diagnostics Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inpouch+t+vaginalis+culture+system/pmc10713349-158-1-7?v=BioMed+Diagnostics+Inc
    Average 93 stars, based on 1 article reviews
    inpouch t vaginalis culture system - by Bioz Stars, 2026-08
    93/100 stars

    Images

    1) Product Images from "Trichomoniasis"

    Article Title: Trichomoniasis

    Journal: Infectious disease clinics of North America

    doi: 10.1016/j.idc.2023.02.001

    2A: 96-well plate used for 5-nitroimidazole drug susceptibility testing. 2B: Graphical representation of a portion of the 96 well plate for the 5-nitroimidazole drug susceptibility testing. Rows A and H are DMSO control lanes, while lanes B-G contain the 5-nitroimdazoles tested for specific T. vaginalis isolates tested in triplicates. 50 μl of media is initially added to each well. Next, 50 μl of drug/media is added to column 1 rows B-G, while 50 μl of DMSO/media are added to A and H and then serially diluted from left to right (column 1 [400 μg/ml] to column 12 [0.2 μg/ml]). 150 μl of the T. vaginalis sample is added to each well from the lowest concentration to the highest (column 12 [0.2 μg/ml] to column 1 [400 μg/ml]). The plates are then incubated for 48 to 52 hours before being read on an inverted microscope. MLC is determined when no motile TV is observed for all three wells with the same concentration.
    Figure Legend Snippet: 2A: 96-well plate used for 5-nitroimidazole drug susceptibility testing. 2B: Graphical representation of a portion of the 96 well plate for the 5-nitroimidazole drug susceptibility testing. Rows A and H are DMSO control lanes, while lanes B-G contain the 5-nitroimdazoles tested for specific T. vaginalis isolates tested in triplicates. 50 μl of media is initially added to each well. Next, 50 μl of drug/media is added to column 1 rows B-G, while 50 μl of DMSO/media are added to A and H and then serially diluted from left to right (column 1 [400 μg/ml] to column 12 [0.2 μg/ml]). 150 μl of the T. vaginalis sample is added to each well from the lowest concentration to the highest (column 12 [0.2 μg/ml] to column 1 [400 μg/ml]). The plates are then incubated for 48 to 52 hours before being read on an inverted microscope. MLC is determined when no motile TV is observed for all three wells with the same concentration.

    Techniques Used: Concentration Assay, Incubation, Inverted Microscopy

    Diagnostic tests for Trichomonas vaginalis
    Figure Legend Snippet: Diagnostic tests for Trichomonas vaginalis

    Techniques Used: Diagnostic Assay, Microscopy, Incubation, Solana Trichomonas Assay, AmpliVue Trichomonas assay



    Similar Products

    inpouch t vaginalis culture system  (BioMed Diagnostics Inc)
    93
    BioMed Diagnostics Inc inpouch t vaginalis culture system
    2A: 96-well plate used for 5-nitroimidazole drug susceptibility testing. 2B: Graphical representation of a portion of the 96 well plate for the 5-nitroimidazole drug susceptibility testing. Rows A and H are DMSO control lanes, while lanes B-G contain the 5-nitroimdazoles tested for specific T. <t>vaginalis</t> isolates tested in triplicates. 50 μl of media is initially added to each well. Next, 50 μl of drug/media is added to column 1 rows B-G, while 50 μl of DMSO/media are added to A and H and then serially diluted from left to right (column 1 [400 μg/ml] to column 12 [0.2 μg/ml]). 150 μl of the T. vaginalis sample is added to each well from the lowest concentration to the highest (column 12 [0.2 μg/ml] to column 1 [400 μg/ml]). The plates are then incubated for 48 to 52 hours before being read on an inverted microscope. MLC is determined when no motile TV is observed for all three wells with the same concentration.
    Inpouch T Vaginalis Culture System, supplied by BioMed Diagnostics Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inpouch+t+vaginalis+culture+system/pmc10713349-158-1-7?v=BioMed+Diagnostics+Inc
    Average 93 stars, based on 1 article reviews
    inpouch t vaginalis culture system - by Bioz Stars, 2026-08
    93/100 stars
    		  Buy from Supplier
    inpouch t. vaginalis culture  (BioMed Diagnostics Inc)
    90
    BioMed Diagnostics Inc inpouch t. vaginalis culture
    2A: 96-well plate used for 5-nitroimidazole drug susceptibility testing. 2B: Graphical representation of a portion of the 96 well plate for the 5-nitroimidazole drug susceptibility testing. Rows A and H are DMSO control lanes, while lanes B-G contain the 5-nitroimdazoles tested for specific T. <t>vaginalis</t> isolates tested in triplicates. 50 μl of media is initially added to each well. Next, 50 μl of drug/media is added to column 1 rows B-G, while 50 μl of DMSO/media are added to A and H and then serially diluted from left to right (column 1 [400 μg/ml] to column 12 [0.2 μg/ml]). 150 μl of the T. vaginalis sample is added to each well from the lowest concentration to the highest (column 12 [0.2 μg/ml] to column 1 [400 μg/ml]). The plates are then incubated for 48 to 52 hours before being read on an inverted microscope. MLC is determined when no motile TV is observed for all three wells with the same concentration.
    Inpouch T. Vaginalis Culture, supplied by BioMed Diagnostics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inpouch+t+vaginalis+culture+system/pmc08442793-88-18-26?v=BioMed+Diagnostics+Inc
    Average 90 stars, based on 1 article reviews
    inpouch t. vaginalis culture - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    t vaginalis inpouch culture  (BioMed Diagnostics Inc)
    93
    BioMed Diagnostics Inc t vaginalis inpouch culture
    2A: 96-well plate used for 5-nitroimidazole drug susceptibility testing. 2B: Graphical representation of a portion of the 96 well plate for the 5-nitroimidazole drug susceptibility testing. Rows A and H are DMSO control lanes, while lanes B-G contain the 5-nitroimdazoles tested for specific T. <t>vaginalis</t> isolates tested in triplicates. 50 μl of media is initially added to each well. Next, 50 μl of drug/media is added to column 1 rows B-G, while 50 μl of DMSO/media are added to A and H and then serially diluted from left to right (column 1 [400 μg/ml] to column 12 [0.2 μg/ml]). 150 μl of the T. vaginalis sample is added to each well from the lowest concentration to the highest (column 12 [0.2 μg/ml] to column 1 [400 μg/ml]). The plates are then incubated for 48 to 52 hours before being read on an inverted microscope. MLC is determined when no motile TV is observed for all three wells with the same concentration.
    T Vaginalis Inpouch Culture, supplied by BioMed Diagnostics Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inpouch+t+vaginalis+culture+system/10__1071_slash_sh11114-21-3-7?v=BioMed+Diagnostics+Inc
    Average 93 stars, based on 1 article reviews
    t vaginalis inpouch culture - by Bioz Stars, 2026-08
    93/100 stars
    		  Buy from Supplier
    inpouch™ t. vaginalis culture system  (BioMed Diagnostics Inc)
    90
    BioMed Diagnostics Inc inpouch™ t. vaginalis culture system
    2A: 96-well plate used for 5-nitroimidazole drug susceptibility testing. 2B: Graphical representation of a portion of the 96 well plate for the 5-nitroimidazole drug susceptibility testing. Rows A and H are DMSO control lanes, while lanes B-G contain the 5-nitroimdazoles tested for specific T. <t>vaginalis</t> isolates tested in triplicates. 50 μl of media is initially added to each well. Next, 50 μl of drug/media is added to column 1 rows B-G, while 50 μl of DMSO/media are added to A and H and then serially diluted from left to right (column 1 [400 μg/ml] to column 12 [0.2 μg/ml]). 150 μl of the T. vaginalis sample is added to each well from the lowest concentration to the highest (column 12 [0.2 μg/ml] to column 1 [400 μg/ml]). The plates are then incubated for 48 to 52 hours before being read on an inverted microscope. MLC is determined when no motile TV is observed for all three wells with the same concentration.
    Inpouch™ T. Vaginalis Culture System, supplied by BioMed Diagnostics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inpouch+t+vaginalis+culture+system/10__1097_slash_olq__0b013e31817bbc89-32-28-33?v=BioMed+Diagnostics+Inc
    Average 90 stars, based on 1 article reviews
    inpouch™ t. vaginalis culture system - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    t. vaginalis inpouch cultures  (BioMed Diagnostics Inc)
    90
    BioMed Diagnostics Inc t. vaginalis inpouch cultures
    2A: 96-well plate used for 5-nitroimidazole drug susceptibility testing. 2B: Graphical representation of a portion of the 96 well plate for the 5-nitroimidazole drug susceptibility testing. Rows A and H are DMSO control lanes, while lanes B-G contain the 5-nitroimdazoles tested for specific T. <t>vaginalis</t> isolates tested in triplicates. 50 μl of media is initially added to each well. Next, 50 μl of drug/media is added to column 1 rows B-G, while 50 μl of DMSO/media are added to A and H and then serially diluted from left to right (column 1 [400 μg/ml] to column 12 [0.2 μg/ml]). 150 μl of the T. vaginalis sample is added to each well from the lowest concentration to the highest (column 12 [0.2 μg/ml] to column 1 [400 μg/ml]). The plates are then incubated for 48 to 52 hours before being read on an inverted microscope. MLC is determined when no motile TV is observed for all three wells with the same concentration.
    T. Vaginalis Inpouch Cultures, supplied by BioMed Diagnostics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inpouch+t+vaginalis+culture+system/pm17143809-52-11-15?v=BioMed+Diagnostics+Inc
    Average 90 stars, based on 1 article reviews
    t. vaginalis inpouch cultures - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    inpouch t. vaginalis culture system  (BioMed Diagnostics Inc)
    90
    BioMed Diagnostics Inc inpouch t. vaginalis culture system
    2A: 96-well plate used for 5-nitroimidazole drug susceptibility testing. 2B: Graphical representation of a portion of the 96 well plate for the 5-nitroimidazole drug susceptibility testing. Rows A and H are DMSO control lanes, while lanes B-G contain the 5-nitroimdazoles tested for specific T. <t>vaginalis</t> isolates tested in triplicates. 50 μl of media is initially added to each well. Next, 50 μl of drug/media is added to column 1 rows B-G, while 50 μl of DMSO/media are added to A and H and then serially diluted from left to right (column 1 [400 μg/ml] to column 12 [0.2 μg/ml]). 150 μl of the T. vaginalis sample is added to each well from the lowest concentration to the highest (column 12 [0.2 μg/ml] to column 1 [400 μg/ml]). The plates are then incubated for 48 to 52 hours before being read on an inverted microscope. MLC is determined when no motile TV is observed for all three wells with the same concentration.
    Inpouch T. Vaginalis Culture System, supplied by BioMed Diagnostics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inpouch+t+vaginalis+culture+system/10__1128_slash_jcm__41__12__5619___5622__2003-38-37-42?v=BioMed+Diagnostics+Inc
    Average 90 stars, based on 1 article reviews
    inpouch t. vaginalis culture system - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    t vaginalis culture  (BioMed Diagnostics Inc)
    93
    BioMed Diagnostics Inc t vaginalis culture
    2A: 96-well plate used for 5-nitroimidazole drug susceptibility testing. 2B: Graphical representation of a portion of the 96 well plate for the 5-nitroimidazole drug susceptibility testing. Rows A and H are DMSO control lanes, while lanes B-G contain the 5-nitroimdazoles tested for specific T. <t>vaginalis</t> isolates tested in triplicates. 50 μl of media is initially added to each well. Next, 50 μl of drug/media is added to column 1 rows B-G, while 50 μl of DMSO/media are added to A and H and then serially diluted from left to right (column 1 [400 μg/ml] to column 12 [0.2 μg/ml]). 150 μl of the T. vaginalis sample is added to each well from the lowest concentration to the highest (column 12 [0.2 μg/ml] to column 1 [400 μg/ml]). The plates are then incubated for 48 to 52 hours before being read on an inverted microscope. MLC is determined when no motile TV is observed for all three wells with the same concentration.
    T Vaginalis Culture, supplied by BioMed Diagnostics Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inpouch+t+vaginalis+culture+system/pm12782954-47-12-17?v=BioMed+Diagnostics+Inc
    Average 93 stars, based on 1 article reviews
    t vaginalis culture - by Bioz Stars, 2026-08
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    2A: 96-well plate used for 5-nitroimidazole drug susceptibility testing. 2B: Graphical representation of a portion of the 96 well plate for the 5-nitroimidazole drug susceptibility testing. Rows A and H are DMSO control lanes, while lanes B-G contain the 5-nitroimdazoles tested for specific T. vaginalis isolates tested in triplicates. 50 μl of media is initially added to each well. Next, 50 μl of drug/media is added to column 1 rows B-G, while 50 μl of DMSO/media are added to A and H and then serially diluted from left to right (column 1 [400 μg/ml] to column 12 [0.2 μg/ml]). 150 μl of the T. vaginalis sample is added to each well from the lowest concentration to the highest (column 12 [0.2 μg/ml] to column 1 [400 μg/ml]). The plates are then incubated for 48 to 52 hours before being read on an inverted microscope. MLC is determined when no motile TV is observed for all three wells with the same concentration.

    Journal: Infectious disease clinics of North America

    Article Title: Trichomoniasis

    doi: 10.1016/j.idc.2023.02.001

    Figure Lengend Snippet: 2A: 96-well plate used for 5-nitroimidazole drug susceptibility testing. 2B: Graphical representation of a portion of the 96 well plate for the 5-nitroimidazole drug susceptibility testing. Rows A and H are DMSO control lanes, while lanes B-G contain the 5-nitroimdazoles tested for specific T. vaginalis isolates tested in triplicates. 50 μl of media is initially added to each well. Next, 50 μl of drug/media is added to column 1 rows B-G, while 50 μl of DMSO/media are added to A and H and then serially diluted from left to right (column 1 [400 μg/ml] to column 12 [0.2 μg/ml]). 150 μl of the T. vaginalis sample is added to each well from the lowest concentration to the highest (column 12 [0.2 μg/ml] to column 1 [400 μg/ml]). The plates are then incubated for 48 to 52 hours before being read on an inverted microscope. MLC is determined when no motile TV is observed for all three wells with the same concentration.

    Article Snippet: The InPouch ® T. vaginalis culture system (BioMed Diagnostics, White City, OR) is the most commonly used culture method and has a sensitivity of 44-81% and specificity of 100%.

    Techniques: Concentration Assay, Incubation, Inverted Microscopy

    Diagnostic tests for Trichomonas vaginalis

    Journal: Infectious disease clinics of North America

    Article Title: Trichomoniasis

    doi: 10.1016/j.idc.2023.02.001

    Figure Lengend Snippet: Diagnostic tests for Trichomonas vaginalis

    Article Snippet: The InPouch ® T. vaginalis culture system (BioMed Diagnostics, White City, OR) is the most commonly used culture method and has a sensitivity of 44-81% and specificity of 100%.

    Techniques: Diagnostic Assay, Microscopy, Incubation, Solana Trichomonas Assay, AmpliVue Trichomonas assay